These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Initial experience with repetitive transarterial chemoembolization (TACE) as a third line treatment of ovarian cancer metastasis to the liver: indications, outcomes and role in patient's management. Vogl TJ; Naguib NN; Lehnert T; Nour-Eldin NE; Eichler K; Zangos S; Gruber-Rouh T Gynecol Oncol; 2012 Feb; 124(2):225-9. PubMed ID: 22079359 [TBL] [Abstract][Full Text] [Related]
26. Transcatheter arterial chemoembolization with doxorubicin-eluting superabsorbent polymer microspheres in the treatment of hepatocellular carcinoma: midterm follow-up. Dekervel J; van Malenstein H; Vandecaveye V; Nevens F; van Pelt J; Heye S; Laleman W; Van Steenbergen W; Vaninbroukx J; Verslype C; Maleux G J Vasc Interv Radiol; 2014 Feb; 25(2):248-55.e1. PubMed ID: 24295569 [TBL] [Abstract][Full Text] [Related]
27. Chemoembolization for hepatocellular carcinoma: 1-month response determined with apparent diffusion coefficient is an independent predictor of outcome. Vandecaveye V; Michielsen K; De Keyzer F; Laleman W; Komuta M; Op de beeck K; Roskams T; Nevens F; Verslype C; Maleux G Radiology; 2014 Mar; 270(3):747-57. PubMed ID: 24475816 [TBL] [Abstract][Full Text] [Related]
28. Hepatic artery infusion chemotherapy using mFOLFOX versus transarterial chemoembolization for massive unresectable hepatocellular carcinoma: a prospective non-randomized study. He MK; Le Y; Li QJ; Yu ZS; Li SH; Wei W; Guo RP; Shi M Chin J Cancer; 2017 Oct; 36(1):83. PubMed ID: 29061175 [TBL] [Abstract][Full Text] [Related]
29. Single-center comparison of three chemoembolization regimens for hepatocellular carcinoma. Petruzzi NJ; Frangos AJ; Fenkel JM; Herrine SK; Hann HW; Rossi S; Rosato EL; Eschelman DJ; Gonsalves CF; Brown DB J Vasc Interv Radiol; 2013 Feb; 24(2):266-73. PubMed ID: 23261143 [TBL] [Abstract][Full Text] [Related]
30. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma. Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905 [TBL] [Abstract][Full Text] [Related]
31. Lipiodol retention pattern assessed by cone beam computed tomography during conventional transarterial chemoembolization of hepatocellular carcinoma: accuracy and correlation with response. Hu J; Maybody M; Cao G; Wang X; Chen H; Zhu X; Yang R; Wang X Cancer Imaging; 2016 Oct; 16(1):32. PubMed ID: 27716376 [TBL] [Abstract][Full Text] [Related]
32. Transarterial administration of integrin inhibitor loaded nanoparticles combined with transarterial chemoembolization for treating hepatocellular carcinoma in a rat model. Qian J; Oppermann E; Tran A; Imlau U; Qian K; Vogl TJ World J Gastroenterol; 2016 Jun; 22(21):5042-9. PubMed ID: 27275096 [TBL] [Abstract][Full Text] [Related]
33. Survival of patients with non-resectable, chemotherapy-resistant colorectal cancer liver metastases undergoing conventional lipiodol-based transarterial chemoembolization (cTACE) palliatively versus neoadjuvantly prior to percutaneous thermal ablation. Vogl TJ; Lahrsow M; Albrecht MH; Hammerstingl R; Thompson ZM; Gruber-Rouh T Eur J Radiol; 2018 May; 102():138-145. PubMed ID: 29685527 [TBL] [Abstract][Full Text] [Related]
34. Rationality and effectiveness of transarterial chemoembolization as an initial treatment for BCLC B stage HBV-related hepatocellular carcinoma. Heng-jun G; Yao-jun Z; Min-shan C; Mei-xian C; Jun-ting H; Li X; Lau WY Liver Int; 2014 Apr; 34(4):612-20. PubMed ID: 24028297 [TBL] [Abstract][Full Text] [Related]
35. Comparison of Triple-Drug Transcatheter Arterial Chemoembolization (TACE) With Single-Drug TACE Using Doxorubicin-Eluting Beads: Long-Term Survival in 313 Patients. Gomes AS; Monteleone PA; Sayre JW; Finn RS; Sadeghi S; Tong MJ; Britten CD; Busuttil RW AJR Am J Roentgenol; 2017 Oct; 209(4):722-732. PubMed ID: 28705059 [TBL] [Abstract][Full Text] [Related]
36. Predicting Treatment Response to Intra-arterial Therapies for Hepatocellular Carcinoma with the Use of Supervised Machine Learning-An Artificial Intelligence Concept. Abajian A; Murali N; Savic LJ; Laage-Gaupp FM; Nezami N; Duncan JS; Schlachter T; Lin M; Geschwind JF; Chapiro J J Vasc Interv Radiol; 2018 Jun; 29(6):850-857.e1. PubMed ID: 29548875 [TBL] [Abstract][Full Text] [Related]